Pharmacoepidemiology and Therapeutic Risk Management play crucial roles in ensuring the safety and effectiveness of pharmaceutical interventions. This interdisciplinary field examines the real-world impact of medications on large populations, identifying patterns of drug use, adverse effects, and therapeutic outcomes. By analyzing data from diverse sources, including healthcare databases and observational studies, pharmacoepidemiologists evaluate drug safety profiles and assess potential risks. Therapeutic Risk Management focuses on minimizing and managing the risks associated with pharmaceutical products throughout their lifecycle. It involves proactive strategies such as risk assessment, risk communication, and risk mitigation plans. Collaborations between healthcare professionals, regulatory agencies, and pharmaceutical companies are essential for successful risk management. The integration of pharmacoepidemiology and therapeutic risk management enhances patient safety by providing evidence-based insights into the benefits and risks of medications. This information guides healthcare practitioners in making informed decisions, optimizing treatment plans, and improving patient outcomes. Continuous monitoring and evaluation of drug safety contribute to a dynamic and responsive healthcare system, fostering trust in the pharmaceutical industry and regulatory processes.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia